Novocure Stock Forecast

Sell candidate since Jul 10, 2026 Gain 0.74%

The NovoCure Limited stock price gained 2.43% on the last trading day (Thursday, 16th Jul 2026), rising from $16.03 to $16.42. During the last trading day the stock fluctuated 3.01% from a day low at $16.04 to a day high of $16.53. The price has been going up and down for this period, and there has been a 4.06% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 120 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $18.03 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 11.89% during the next 3 months and, with a 90% probability hold a price between $15.40 and $22.19 at the end of this 3-month period.

NVCR Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The NovoCure Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $16.44 and $16.43. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, May 12, 2026, and so far it has fallen -10.32%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for NovoCure Limited stock

On the downside, the stock finds support just below today's level from accumulated volume at $15.43 and $15.21. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, NovoCure Limited finds support just below today's level at $15.43. If this is broken, then the next support from accumulated volume will be at $15.21 and $14.28.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.483 between high and low, or 3.01%. For the last week, the stock has had daily average volatility of 5.07%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NVCR) For The Upcoming Trading Day Of Friday 17th

For the upcoming trading day on Friday, 17th we expect NovoCure Limited to open at $16.33, and during the day (based on 14 day Average True Range), to move between $15.95 and $16.89, which gives a possible trading interval of +/-$0.94 (+/-5.89%) up or down from last closing price. If NovoCure Limited takes out the full calculated possible swing range there will be an estimated 5.89% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $16.62 (1.22%) than the support at $15.43 (6.03%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is NovoCure Limited stock A Buy?

The NovoCure Limited stock holds several negative signals and despite the positive trend, we believe NovoCure Limited will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.132 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 17, 2026 - $16.33 ( 0.555%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk